Wells Fargo’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Sell
35,158
-56,441
-62% -$1.54M ﹤0.01% 3678
2025
Q4
$2.49M Buy
91,599
+23,843
+35% +$628K ﹤0.01% 3264
2025
Q3
$1.75M Buy
67,756
+24,480
+57% +$567K ﹤0.01% 3406
2025
Q2
$881K Buy
43,276
+9,898
+30% +$193K ﹤0.01% 3772
2025
Q1
$606K Buy
33,378
+880
+3% +$19.7K ﹤0.01% 3959
2024
Q4
$821K Buy
32,498
+10,087
+45% +$274K ﹤0.01% 3846
2024
Q3
$762K Sell
22,411
-325
-1% -$12.4K ﹤0.01% 3720
2024
Q2
$841K Buy
22,736
+1,121
+5% +$42.3K ﹤0.01% 3605
2024
Q1
$907K Buy
21,615
+6,861
+47% +$282K ﹤0.01% 3525
2023
Q4
$585K Sell
14,754
-27,075
-65% -$796K ﹤0.01% 3762
2023
Q3
$1.15M Sell
41,829
-12,272
-23% -$385K ﹤0.01% 3231
2023
Q2
$1.84M Buy
54,101
+20,516
+61% +$691K ﹤0.01% 2985
2023
Q1
$1.21M Buy
33,585
+32,538
+3,108% +$1.4M ﹤0.01% 3248
2022
Q4
$46.7K Sell
1,047
-1,517
-59% -$54.2K ﹤0.01% 4894
2022
Q3
$73K Sell
2,564
-244
-9% -$7.48K ﹤0.01% 4764
2022
Q2
$75K Sell
2,808
-30,023
-91% -$872K ﹤0.01% 4816
2022
Q1
$1.12M Sell
32,831
-13,881
-30% -$444K ﹤0.01% 3787
2021
Q4
$1.81M Buy
46,712
+26,527
+131% +$1.16M ﹤0.01% 3602
2021
Q3
$1.09M Buy
20,185
+20,036
+13,447% +$940K ﹤0.01% 4172
2021
Q2
$5K Sell
149
-20
-12% -$549 ﹤0.01% 6327
2021
Q1
$3K Sell
169
-49,328
-100% -$1.13M ﹤0.01% 6577
2020
Q4
$866K Buy
49,497
+49,115
+12,857% +$884K ﹤0.01% 4136
2020
Q3
$6K Buy
382
+131
+52% +$1.53K ﹤0.01% 5975
2020
Q2
$3K Sell
251
-79
-24% -$350 ﹤0.01% 6050
2020
Q1
$0 Buy
330
+25
+8% +$56 ﹤0.01% 6241
2019
Q4
$0 Buy
305
+80
+36% +$186 ﹤0.01% 6374
2019
Q3
$0 Sell
225
-348
-61% -$805 ﹤0.01% 6400
2019
Q2
$1K Buy
573
+92
+19% +$312 ﹤0.01% 6236
2019
Q1
$2K Buy
481
+326
+210% +$1.72K ﹤0.01% 5853
2018
Q4
$0 Hold
155
﹤0.01% 6412
2018
Q3
$1K Sell
155
-220
-59% -$1.54K ﹤0.01% 6281
2018
Q2
$3K Sell
375
-5,166
-93% -$69.1K ﹤0.01% 6137
2018
Q1
$194K Buy
5,541
+1,296
+31% +$50.2K ﹤0.01% 4999
2017
Q4
$180K Sell
4,245
-1,487
-26% -$63.7K ﹤0.01% 5007
2017
Q3
$246K Buy
5,732
+479
+9% +$18K ﹤0.01% 4815
2017
Q2
$195K Sell
5,253
-107
-2% -$4.73K ﹤0.01% 4801
2017
Q1
$291K Sell
5,360
-800
-13% -$41.7K ﹤0.01% 4587
2016
Q4
$327K Buy
6,160
+934
+18% +$53.1K ﹤0.01% 4478
2016
Q3
$317K Buy
5,226
+1,245
+31% +$77.5K ﹤0.01% 4213
2016
Q2
$262K Sell
3,981
-95
-2% -$6.03K ﹤0.01% 4263
2016
Q1
$231K Sell
4,076
-33,440
-89% -$3.76M ﹤0.01% 4317
2015
Q4
$8.82M Sell
37,516
-3,675
-9% -$801K ﹤0.01% 1934
2015
Q3
$6.51M Buy
41,191
+10,773
+35% +$3.05M ﹤0.01% 2125
2015
Q2
$11.5M Buy
30,418
+8,709
+40% +$3.46M ﹤0.01% 1800
2015
Q1
$8.99M Sell
21,709
-2,861
-12% -$1.02M ﹤0.01% 1969
2014
Q4
$6.73M Buy
24,570
+21,484
+696% +$5.34M ﹤0.01% 2108
2014
Q3
$600K Sell
3,086
-679
-18% -$148K ﹤0.01% 3780
2014
Q2
$922K Sell
3,765
-2,379
-39% -$537K ﹤0.01% 3580
2014
Q1
$1.63M Buy
6,144
+2,443
+66% +$935K ﹤0.01% 3125
2013
Q4
$1.34M Buy
3,701
+2,100
+131% +$809K ﹤0.01% 3214
2013
Q3
$850K Buy
1,601
+1,362
+570% +$467K ﹤0.01% 3451
2013
Q2
$56K Buy
+239
New +$47.1K ﹤0.01% 4577

Other funds holding CLDX